| Mon, Feb 8, 2010 |
| • |
Biotech ETFs Immune To Broad Selling
Investor's Business Daily (Mon, Feb 8)
|
| Thu, Feb 4, 2010 |
| • |
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
EDGAR Online (Thu, Feb 4)
|
| Wed, Feb 3, 2010 |
| • |
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financia
EDGAR Online (Wed, Feb 3)
|
| Tue, Feb 2, 2010 |
| • |
Nektar appoints Greer to board
AP (Tue, Feb 2)
|
| • |
Nektar adds to board of directors
at bizjournals.com (Tue, Feb 2)
|
| • |
Nektar Therapeutics Appoints R. Scott Greer to Board of Directors
PRNewswire (Tue, Feb 2)
|
| Mon, Feb 1, 2010 |
| • |
Symantec adds former Intuit CEO to board
at bizjournals.com (Mon, Feb 1)
|
| Tue, Jan 26, 2010 |
| • |
3 Stocks Ready to Roar
at Motley Fool (Tue, Jan 26)
|
| • |
Wall Street's Buy List
at Motley Fool (Tue, Jan 26)
|
| Mon, Jan 25, 2010 |
| • |
Earnings Surprises For Diagnostics Companies Creates Good Stock Price Entry Point For New Investors According To Industry Expert
Wall Street Transcript (Mon, Jan 25)
|
| Wed, Jan 13, 2010 |
| • |
Tech Showing Signs of Life
Indie Research (Wed, Jan 13)
|
| • |
Preliminary Data from Nektar
Zacks.com (Wed, Jan 13)
|
| Tue, Jan 12, 2010 |
| • |
UPDATE - Nektar posts prelim data from cancer trial
at Reuters (Tue, Jan 12)
|
| • |
NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Jan 12)
|
| • |
Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer
PRNewswire (Tue, Jan 12)
|
| Mon, Jan 11, 2010 |
| • |
Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors
CNW Group (Mon, Jan 11)
|
| • |
Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors
PRNewswire (Mon, Jan 11)
|
| Wed, Jan 6, 2010 |
| • |
Nektar names first chief science officer
at bizjournals.com (Wed, Jan 6)
|
| • |
Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer
PRNewswire (Wed, Jan 6)
|
| • |
Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
PRNewswire (Wed, Jan 6)
|
| Older Headlines |
|
|
|
|
Help
0.31 (2.72%) 
Headlines
